Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Sell
3,108
-860
-22% -$271K 0.5% 39
2026
Q1
$1.3M Sell
3,968
-12
-0.3% -$4.31K 0.79% 28
2025
Q4
$1.4M Buy
3,980
+197
+5% +$71.8K 0.82% 26
2025
Q3
$1.4M Buy
3,783
+86
+2% +$33.2K 0.81% 29
2025
Q2
$1.46M Buy
3,697
+34
+0.9% +$12.7K 0.94% 26
2025
Q1
$1.36M Buy
3,663
+130
+4% +$49.5K 1% 27
2024
Q4
$1.27M Buy
3,533
+40
+1% +$14.8K 0.9% 30
2024
Q3
$1.26M Buy
3,493
+11
+0.3% +$3.8K 0.95% 27
2024
Q2
$1.18M Sell
3,482
-2
-0.1% -$677 0.89% 27
2024
Q1
$1.25M Sell
3,484
-223
-6% -$75K 0.95% 26
2023
Q4
$1.11M Buy
+3,707
New +$1.04M 0.92% 29

Other funds holding SYK

SFM LLC's SYK Position: Q2 2026 in Review

SFM LLC reduced its Stryker (SYK) stake by 22% in Q2 2026, selling an estimated $271K and leaving 3,108 shares worth $978K. The position accounts for 0.5% of the portfolio, ranked #39.

SFM LLC first reported a position in SYK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.46M in Q2 2025. 716 funds tracked by Wall St. Rank hold SYK as of Q2 2026.

  • SFM LLC held 3,108 shares of Stryker worth $978K as of Q2 2026.
  • SFM LLC sold 860 Stryker shares in Q2 2026, an estimated $271K.
  • Stryker made up 0.5% of SFM LLC's portfolio in Q2 2026, its #39 holding.
  • SFM LLC first reported a position in Stryker in Q4 2023 and has held it in 11 quarters since.
  • SFM LLC's Stryker position peaked at $1.46M in Q2 2025.
  • 716 funds tracked by Wall St. Rank held Stryker as of Q2 2026.

Based on SFM LLC's 13F filing for Q2 2026, filed 7 Jul 2026.